Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the afternoon session after the company announced the launch ...

Expands pharma access to large omics datasets to advance target discovery and drug development ...

Life sciences company Element Biosciences sued Illumina on Monday in separate cases in federal courts in California and ...

Shares of Illumina, Inc. (ILMN) rose 6% on Wednesday afternoon after the biotechnology company announced the launch of a new ...

"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," ...

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.3% in the afternoon session after an analyst at ...

Illumina Inc. (NASDAQ:ILMN) ranks among the top NASDAQ stocks with low P/E ratios. On September 23, Illumina Inc.

Analysts have set 12-month price targets for Illumina, revealing an average target of $106.56, a high estimate of $128.00, and a low estimate of $80.00. Witnessing a positive shift, the current ...

FILE PHOTO: A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California (Reuters) - Illumina said on Tuesday it has partnered with the Broad Institute to ...

Longstanding partners bring together end-to-end workflows and leading CRISPRPerturb-seq technologies setting a standard for single-cell studies and enabling a 5billion single-cell atlas ecosystem ...

SAN DIEGO — The unwinding of Illumina’s ill-fated acquisition of Grail earlier this year left investors and the genomics community with a pressing question: What kind of company is Illumina going to ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at ...